A detailed history of Pdt Partners, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Pdt Partners, LLC holds 280,382 shares of ADPT stock, worth $1.77 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
280,382
Previous 215,004 30.41%
Holding current value
$1.77 Million
Previous $778,000 84.45%
% of portfolio
0.14%
Previous 0.08%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.37 - $5.12 $220,323 - $334,735
65,378 Added 30.41%
280,382 $1.44 Million
Q1 2024

May 15, 2024

BUY
$2.88 - $4.8 $282,816 - $471,360
98,200 Added 84.07%
215,004 $690,000
Q4 2023

Feb 14, 2024

BUY
$3.46 - $5.33 $348,923 - $537,503
100,845 Added 631.9%
116,804 $572,000
Q3 2023

Nov 14, 2023

SELL
$5.07 - $8.44 $559,646 - $931,640
-110,384 Reduced 87.37%
15,959 $86,000
Q2 2023

Aug 14, 2023

BUY
$6.19 - $8.78 $115,653 - $164,045
18,684 Added 17.35%
126,343 $847,000
Q1 2023

May 15, 2023

BUY
$7.8 - $10.11 $124 - $161
16 Added 0.01%
107,659 $950,000
Q4 2022

Feb 14, 2023

BUY
$6.26 - $9.34 $340,030 - $507,330
54,318 Added 101.86%
107,643 $822,000
Q3 2022

Nov 14, 2022

SELL
$6.5 - $12.67 $42,692 - $83,216
-6,568 Reduced 10.97%
53,325 $380,000
Q2 2022

Aug 15, 2022

SELL
$6.4 - $14.73 $2,297 - $5,288
-359 Reduced 0.6%
59,893 $485,000
Q1 2022

May 16, 2022

SELL
$10.12 - $28.9 $243,365 - $694,987
-24,048 Reduced 28.53%
60,252 $836,000
Q4 2021

Feb 14, 2022

SELL
$25.17 - $36.85 $341,607 - $500,128
-13,572 Reduced 13.87%
84,300 $2.37 Million
Q3 2021

Nov 15, 2021

BUY
$30.02 - $39.87 $62,081 - $82,451
2,068 Added 2.16%
97,872 $3.33 Million
Q2 2021

Aug 16, 2021

BUY
$32.22 - $44.59 $41,499 - $57,431
1,288 Added 1.36%
95,804 $3.92 Million
Q1 2021

May 17, 2021

SELL
$37.26 - $67.74 $538,146 - $978,368
-14,443 Reduced 13.26%
94,516 $3.81 Million
Q4 2020

Feb 16, 2021

SELL
$45.01 - $65.47 $2.66 Million - $3.87 Million
-59,048 Reduced 35.15%
108,959 $6.44 Million
Q3 2020

Nov 16, 2020

BUY
$35.79 - $48.81 $5.64 Million - $7.69 Million
157,594 Added 1513.44%
168,007 $8.17 Million
Q2 2020

Aug 14, 2020

BUY
$24.95 - $48.38 $259,804 - $503,780
10,413 New
10,413 $504,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $903M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.